Effect of intrauterine injection of platelet-rich plasma on pregnancy outcome
Phase 3
Recruiting
- Conditions
- Female infertility of uterine origin.Female infertility of uterine originN97.2
- Registration Number
- IRCT20240119060732N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Age 20 to 38 years
Body mass index below 30
Patients with embryo quality A or B
Endometrial thickness less than 7 mm despite receiving hormonal treatment
With a history of IVF failure
Exclusion Criteria
Patients with diabetes
Use of immune system suppressing drugs
Patients with malignancy
Uterine myomatosis or adenomyosis or hydrosalpingus
Endometriosis stage 4
The presence of acute pelvic infection
The presence of blood or platelet disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: Once, six weeks after fetal transfer. Method of measurement: Ultrasound.
- Secondary Outcome Measures
Name Time Method